 |
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Lyase
|
 |
|
Title:
|
 |
A novel mechanism for adenylyl cyclase inhibition from the crystal structure of its complex with catechol estrogen
|
|
Structure:
|
 |
Adenylate cyclase. Chain: a, b, c, d. Fragment: catalytic domain, residues 1005-1199. Synonym: soluble adenylyl cyclase cyac. Engineered: yes
|
|
Source:
|
 |
Spirulina platensis. Organism_taxid: 118562. Expressed in: escherichia coli. Expression_system_taxid: 469008.
|
|
Biol. unit:
|
 |
Dimer (from PDB file)
|
|
Resolution:
|
 |
|
2.30Å
|
R-factor:
|
0.207
|
R-free:
|
0.257
|
|
|
Authors:
|
 |
C.Steegborn,T.N.Litvin,K.C.Hess,A.B.Capper,R.Taussig,J.Buck, L.R.Levin,H.Wu
|
Key ref:
|
 |
C.Steegborn
et al.
(2005).
A novel mechanism for adenylyl cyclase inhibition from the crystal structure of its complex with catechol estrogen.
J Biol Chem,
280,
31754-31759.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
12-Jul-05
|
Release date:
|
20-Jul-05
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
O32393
(O32393_SPIPL) -
Adenylate cyclase
|
|
|
|
Seq: Struc:
|
 |
 |
 |
1202 a.a.
198 a.a.*
|
|
|
|
|
|
|
 |
 |
|
|
Key: |
 |
PfamA domain |
 |
 |
 |
Secondary structure |
 |
 |
CATH domain |
 |
|
*
PDB and UniProt seqs differ
at 3 residue positions (black
crosses)
|
|
|
|
|
 |
|
|
 |
 |
 |
 |
Enzyme class:
|
 |
E.C.4.6.1.1
- Adenylate cyclase.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
ATP = 3',5'-cyclic AMP + diphosphate
|
 |
 |
 |
 |
 |
ATP
|
=
|
3',5'-cyclic AMP
Bound ligand (Het Group name = )
matches with 70.00% similarity
|
+
|
diphosphate
|
|
 |
 |
 |
 |
 |
 |
 |
 |
Cofactor:
|
 |
Pyridoxal 5'-phosphate
|
 |
 |
 |
 |
 |
Pyridoxal 5'-phosphate
|
|
 |
 |
 |
 |
|
Molecule diagrams generated from .mol files obtained from the
KEGG ftp site
|
|
 |
 |
|
 |
|
 |
|
|
Gene Ontology (GO) functional annotation
|
|
|
|
 |
 |
 |
|
 |
 |
 |
 |
|
 |
|
Biological process
|
cyclic nucleotide biosynthetic process
|
1 term
|
 |
|
Biochemical function
|
phosphorus-oxygen lyase activity
|
1 term
|
 |
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
| |
|
DOI no:
|
J Biol Chem
280:31754-31759
(2005)
|
|
PubMed id:
|
|
|
|
|
| |
|
A novel mechanism for adenylyl cyclase inhibition from the crystal structure of its complex with catechol estrogen.
|
|
C.Steegborn,
T.N.Litvin,
K.C.Hess,
A.B.Capper,
R.Taussig,
J.Buck,
L.R.Levin,
H.Wu.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Catechol estrogens are steroid metabolites that elicit physiological responses
through binding to a variety of cellular targets. We show here that catechol
estrogens directly inhibit soluble adenylyl cyclases and the abundant
trans-membrane adenylyl cyclases. Catechol estrogen inhibition is
non-competitive with respect to the substrate ATP, and we solved the crystal
structure of a catechol estrogen bound to a soluble adenylyl cyclase from
Spirulina platensis in complex with a substrate analog. The catechol estrogen is
bound to a newly identified, conserved hydrophobic patch near the active center
but distinct from the ATP-binding cleft. Inhibitor binding leads to a chelating
interaction between the catechol estrogen hydroxyl groups and the catalytic
magnesium ion, distorting the active site and trapping the enzyme substrate
complex in a non-productive conformation. This novel inhibition mechanism likely
applies to other adenylyl cyclase inhibitors, and the identified ligand-binding
site has important implications for the development of specific adenylyl cyclase
inhibitors.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 1.
FIG. 1. Chemical structures of estrogen and its
metabolites. The catechol derivatives 2-CE, 4-CE, and
2-hydroxyestrone are major catabolites of the steroid hormones
estrogen and estrone. The hydroxyl group added to the sterol
scaffold is needed for subsequent conjugation and decomposition
reactions.
|
 |
Figure 3.
FIG. 3. Structure of CyaC in complex with CE. A, kinetic
mechanism for the inhibition of CyaC by 2-CE. AC activities
determined at varying substrate and inhibitor concentrations are
displayed in a double reciprocal plot. The linear extrapolations
intersect on the x-axis, indicating that CE inhibition is
non-competitive with the substrate ATP. B, overall structure of
CyaC in complex with the substrate analog , -Me-ATP and the
inhibitor 2-CE. The two monomers of the homodimer are shown in
red and blue, respectively. Two inhibitor molecules occupy the
center of the dimer, whereas the active sites are still occupied
by the substrate analog and two metal ions. C, detailed view of
the interactions between CyaC and the inhibitor 2-CE bound next
to the active site, which harbors the substrate analog , -Me-ATP
and two divalent metal ions (one magnesium ion colored cyan, and
one calcium ion in gray). F[o] - F[c] omit electron density for
the inhibitor is shown contoured at 2.5 . Single letter amino
acid abbreviations are presented with position numbers. D,
electrostatic surface of the 2-CE binding site showing its
mainly hydrophobic nature (blue, positively charged; red,
negatively charged). The hydroxyl groups of the inhibitor
chelate the catalytic magnesium ion (ion A), removing it from
its normal binding site (indicated in gray).
|
 |
|
|
|
| |
The above figures are
reprinted
by permission from the ASBMB:
J Biol Chem
(2005,
280,
31754-31759)
copyright 2005.
|
|
| |
Figures were
selected
by an automated process.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
M.Tresguerres,
J.Buck,
and
L.R.Levin
(2010).
Physiological carbon dioxide, bicarbonate, and pH sensing.
|
| |
Pflugers Arch, 460,
953-964.
|
 |
|
|
|
|
 |
M.Tresguerres,
S.K.Parks,
E.Salazar,
L.R.Levin,
G.G.Goss,
and
J.Buck
(2010).
Bicarbonate-sensing soluble adenylyl cyclase is an essential sensor for acid/base homeostasis.
|
| |
Proc Natl Acad Sci U S A, 107,
442-447.
|
 |
|
|
|
|
 |
B.Pavan,
C.Biondi,
and
A.Dalpiaz
(2009).
Adenylyl cyclases as innovative therapeutic goals.
|
| |
Drug Discov Today, 14,
982-991.
|
 |
|
|
|
|
 |
K.R.Hallows,
H.Wang,
R.S.Edinger,
M.B.Butterworth,
N.M.Oyster,
H.Li,
J.Buck,
L.R.Levin,
J.P.Johnson,
and
N.M.Pastor-Soler
(2009).
Regulation of epithelial Na+ transport by soluble adenylyl cyclase in kidney collecting duct cells.
|
| |
J Biol Chem, 284,
5774-5783.
|
 |
|
|
|
|
 |
L.Mann,
E.Heldman,
Y.Bersudsky,
S.F.Vatner,
Y.Ishikawa,
O.Almog,
R.H.Belmaker,
and
G.Agam
(2009).
Inhibition of specific adenylyl cyclase isoforms by lithium and carbamazepine, but not valproate, may be related to their antidepressant effect.
|
| |
Bipolar Disord, 11,
885-896.
|
 |
|
|
|
|
 |
S.Pierre,
T.Eschenhagen,
G.Geisslinger,
and
K.Scholich
(2009).
Capturing adenylyl cyclases as potential drug targets.
|
| |
Nat Rev Drug Discov, 8,
321-335.
|
 |
|
|
|
|
 |
C.Schlicker,
A.Rauch,
K.C.Hess,
B.Kachholz,
L.R.Levin,
J.Buck,
and
C.Steegborn
(2008).
Structure-based development of novel adenylyl cyclase inhibitors.
|
| |
J Med Chem, 51,
4456-4464.
|
 |
|
|
|
|
 |
A.Schmid,
Z.Sutto,
M.C.Nlend,
G.Horvath,
N.Schmid,
J.Buck,
L.R.Levin,
G.E.Conner,
N.Fregien,
and
M.Salathe
(2007).
Soluble adenylyl cyclase is localized to cilia and contributes to ciliary beat frequency regulation via production of cAMP.
|
| |
J Gen Physiol, 130,
99.
|
 |
|
|
|
|
 |
A.M.Stessin,
J.H.Zippin,
M.Kamenetsky,
K.C.Hess,
J.Buck,
and
L.R.Levin
(2006).
Soluble adenylyl cyclase mediates nerve growth factor-induced activation of Rap1.
|
| |
J Biol Chem, 281,
17253-17258.
|
 |
|
|
|
|
 |
D.C.Meadows,
D.J.Tantillo,
and
J.Gervay-Hague
(2006).
Correlation of biological activity with active site binding modes of geminal disulfone HIV-1 integrase inhibitors.
|
| |
ChemMedChem, 1,
959-964.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
|
|